3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
3
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
5
Triple Negative Breast Neoplasms
2
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Cardiotoxicity
1
Carcinoma
1
Atrial Fibrillation
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
17
Docetaxel
13
Specimen Handling
12
Radiotherapy
11
Surveys and Questionnaires
10
Cyclophosphamide
10
Blood Specimen Collection
9
Radiosurgery
8
Paclitaxel
8
Gemcitabine
8
Drug Therapy
8
sargramostim
7
Trastuzumab
7
Nivolumab
7
Carboplatin
7
Injections
6
Early Intervention, Educational
6
Taxes
5
Psychiatric Rehabilitation
5
Methods
5
Interviews as Topic
5
Educational Status
5
spartalizumab
4
motexafin gadolinium
4
aldesleukin
4
X-Rays
4
Therapeutics
4
Standard of Care
4
Spinal Puncture
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Electrocardiography
×
Breast
×
Clear all
NCT05927246
2023-07-03
RADAF
Istanbul University
Completed
400 enrolled